Please login to the form below

Not currently logged in
Email:
Password:

market access

This page shows the latest market access news and features for those working in and with pharma, biotech and healthcare.

We've got this!

We've got this!

And the changes haven’t only been scientific. Look at globalisation, market access, lifestyle diseases and other sociological transformations. ... These were all changes that fundamentally changed the market environment to which the industry was well

Latest news

  • Prime Global launches new market access consultancy Prime Global launches new market access consultancy

    Medical communications agency Prime Global has launched a new market access consultancy named Prime Access Consultancy. ... agencies. They will also aim to create new relationships with clients who value consultants with first-hand knowledge of the

  • Genactis, emotive and Initiate join forces to create Synaptic Health Genactis, emotive and Initiate join forces to create Synaptic Health

    Finally, the Access competent will be led by global market access and strategy consultancy Initiate, whose principals have several decades of experience in both consultancy and industry across multiple therapy areas. ... Synaptiq Health will deliver an

  • Blood will out Blood will out

    Was it, for example, brand building or achieving market access? Then, which routines (sustained patterns of behaviour) were responsible for those capabilities?

  • 20/20 vision 20/20 vision

    We only need to look at the vaccine market to understand how dangerous this can be in healthcare. ... These treatments are under more pressure to come to market quickly,  which creates a clear market access challenge, with the price of drugs increasing

  • FDA delays decision on Intercept's NASH drug by three months FDA delays decision on Intercept's NASH drug by three months

    As it stands, Intercept is poised to access the NASH market before its larger rivals but it is unclear if that first-mover advantage will translate into commercial success. ... Non-invasive tests are in development but obeticholic acid is on course to

More from news
Approximately 133 fully matching, plus 421 partially matching documents found.

Latest Intelligence

  • Could formulary intelligence be your brand differentiator?

    Competitive advantage. Relative formulary status is the gateway (or the barrier) to market access. ... Understanding – and planning around – them requires in-depth knowledge of complex market access environments.

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    disease. Is there a way to accelerate patient access to medicines for earlystage cancers in the interim? ... Jason Ward is Head of Haematology and Group Director, Strategy, Policy &Operations, Oncology Market Access and Pricing at AstraZeneca.

  • War games: why brand teams need a cunning plan that cannot fail War games: why brand teams need a cunning plan that cannot fail

    The strategic plan, owned by the client, is driven by business goals and objectives based on metrics like approvals, sales, margin and market share. ... and reimbursement and market access; general management, portfolio leadership, therapy P&L holders;

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    The access landscape is further complicated because many health technology assessment (HTA) methodologies are currently not geared up to evaluate these treatments. ... Yet a product only succeeds if patients can access it, and smooth market entry in AD.

  • BRIC markets BRIC markets

    Market access. Access strategies are also evolving. Initially multinational pharmaceutical companies entered BRIC markets by teaming up with local manufactures. ... Kleinrock said: “The early entry strategy for multinational pharmaceutical companies

More from intelligence
Approximately 59 fully matching, plus 141 partially matching documents found.

Latest appointments

More from appointments
Approximately 4 fully matching, plus 91 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 65 fully matching, plus 479 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics